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Shiga toxin producing Escherichia coli may damage the central nervous system before
or concomitantly to manifested hemolytic–uremic syndrome symptoms. The cerebellum
is frequently damaged during this syndrome, however, the deleterious effects of Shiga
toxin 2 has never been integrally reported by ultrastructural, physiological and behavioral
means. The aim of this study was to determine the cerebellar compromise after
intravenous administration of a sub-lethal dose of Shiga toxin 2 by measuring the
cerebellar blood–brain barrier permeability, behavioral task of cerebellar functionality
(inclined plane test), and ultrastructural analysis (transmission electron microscope).
Intravenous administration of vehicle (control group), sub-lethal dose of 0.5 and 1 ηg
of Stx2 per mouse were tested for behavioral and ultrastructural studies. A set of
three independent experiments were performed for each study (n = 6). Blood–brain
barrier resulted damaged and consequently its permeability was significantly increased.
Lower scores obtained in the inclined plane task denoted poor cerebellar functionality
in comparison to their controls. The most significant lower score was obtained after
5 days of 1 ηg of toxin administration. Transmission electron microscope micrographs
from the Stx2-treated groups showed neurons with a progressive neurodegenerative
condition in a dose dependent manner. As sub-lethal intravenous Shiga toxin 2 altered
the blood brain barrier permeability in the cerebellum the toxin penetrated the cerebellar
parenchyma and produced cell damaged with significant functional implications in the
test balance.
Keywords: cerebellum, neurodegeneration, transmission electron microscopy, fluorescence microscopy, blood–
brain barrier
Abbreviations: BBB, blood–brain barrier; HUS, Hemolytic–Uremic Syndrome; Stx 2, Shiga toxin 2; TEM, transmission
electron microscopy.
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INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) causes
hemorrhagic colitis which may leads to HUS (O’Brien and Kaper,
1998), resulting in symptoms which include: thrombocytopenia,
microangiopathic hemolytic anemia, and acute renal failure
(Proulx et al., 2001).
At present, Argentina has the highest number of HUS cases
with about 420 new cases reported annually, aﬀecting 17/100,000
children under the age of ﬁve (Rivas et al., 2010). It has been
reported that the mortality rate derived from HUS ranges up
to 5% of the cases, and between 7 and 40% when the central
nervous system (CNS) is involved (Eriksson et al., 2001; Noris
and Remuzzi, 2005; Repetto, 2005; Oakes et al., 2006; Magnus
et al., 2012). Furthermore, in 2011, Europe’s largest reported
STEC outbreak started in northern Germany had higher rate of
neurologic complications (Trachtman et al., 2012). Probably due
to a new variant, which expresses not only the potent Stx2, but
also enteroaggregative elements that conferred a major toxicity
(Frank et al., 2011; Weissenborn et al., 2012).
Damage in the CNS may occur before or concomitantly
with other symptoms of the systemic HUS disease (Brascher
and Siegler, 1981; Karmali et al., 1985). Common clinical signs
of severe CNS injury included focal seizures, changes in the
level of consciousness (from lethargy to coma), hemiparesis,
descerebrate posture, cortical blindness, ataxia, cranial nerve
palsy, hallucinations, and brain stem symptoms (Gianantonio
et al., 1973; Cimolai et al., 1992; Hamano et al., 1993; Tapper
et al., 1995; Hager et al., 1999). Mice models of Stx2 intoxication
matched with neurological symptoms observed in human
patients and others common in rodents: lethargy, spasm-like
seizure, reduced spontaneous motor activity, abnormal gait, hind
limb paralysis, pelvic elevation and shivering (Obata et al., 2008;
Tironi-Farinati et al., 2013). In addition, studies performed by
TEM revealed subtle but signiﬁcant changes in the brains of
animal administered with high-dose Stx, these changes included
neuronal, ﬁber, and glial ultrastructural alterations. The principal
areas aﬀected were neocortex, cerebellum and basal ganglia (Fujii
et al., 1994, 1996, 1998; Mizuguchi et al., 1996; Fletcher et al.,
1999; Goldstein et al., 2007).
It has been observed that the cerebellum is frequently
damaged in patients with HUS (Weissenborn et al., 2012). Most
frequent neurologic symptoms included: dysdiadochokinesis,
dysmetria, intention tremor, cerebellar ataxia, dysarthria, and
nystagmus (Weissenborn et al., 2012). However, research in this
ﬁeld has been scarce requiring a more integrative approach
(Mizuguchi et al., 1996; Fujii et al., 1998; Mewasingh et al.,
2003). Therefore, the current work attempts to integrate the
physiological, behavioral and ultrastructural implications of
cerebellar functioning caused by Stx2 addressed for the ﬁrst time.
MATERIALS AND METHODS
Sub-Lethal Dose
The canonical Stx2 used was obtained from phage 933W, named
Stx2a (Plunkett et al., 1999). It was purchased at Phoenix
Laboratory, Tufts Medical Center, Boston, MA, USA and were
checked for lipopolysaccharide (LPS) contamination by the
Limulus amoebocyte lysate assay. It contained <10 pg LPS/ng
of pure Stx2. Diﬀerent amounts of Stx2 (5–0.44 ηg per animal)
or vehicle were intravenously (i.v.) administered in mice, as
previously described (Tironi-Farinati et al., 2013). Survival time
was considered when 100 % of the animals survived with an
administration of 1 ηg of Stx2 or less amount for at least 8 days.
Also it was observed that under these dose mice did not die even
at day 10. Therefore, this amount was considered sub-lethal and
selected to use for the present work.
Animals
Male NIH mice (25–30 g) were housed in an air conditioned
and light-controlled (lights between 07:00 and 19:00 h) animal
facility. Test animal were obtained from animal facility center
from Administración Nacional de laboratorios e Institutos de la
Salud (ANLIS), Malbrán, Argentina. Mice were provided with
food and water ad libitum. They were daily monitored at the same
time for neurological manifestations from the beginning of the
experiments until the last day.
For all studies a set of three independent experiments were
performed. Mice were divided into three groups (n = 6):
animals treated with vehicle (control), with a sub-lethal i.v.
administration of Stx2 (1 ηg per mouse), and with half of sub-
lethal i.v. administration of Stx2 (0.5 ηg per mouse). The three
groups were tested for behavioral and ultrastructural studies
following Stx2 administration.
The experimental protocols and euthanasia procedures were
reviewed and approved by the Institutional Animal Care and
Use Committee of Buenos Aires University School of Medicine
(Resolution N◦ 2437/2012). All procedures were performed in
accordance with the guidelines for care and use of experimental
animals (EEC Council 86/609).
BBB Permeability Test
This test was performed, as described by (del Valle et al., 2008).
Mice were divided into two groups (n = 4): animals were i.v.
treated with saline as vehicle (control group) or with a sub-lethal
administration of 1 ηg of Stx2. After their respective treatments at
day 4 they were perfused transcardially with 0.9% NaCl solution
followed by a solution with 4% paraformaldehyde, and 1% Evans
Blue (EB) in 0.1 M phosphate buﬀer solution (PBS) [ﬁxative
per animal weight (ml/g)]. Cerebella were removed from the
skull and post-ﬁxed with the same ﬁxative solution (without
the EB staining) for 2 h (del Valle et al., 2008). Cerebellar
coronal sections (25 μm thick) were mounted on slides with
a solution of glycerol and PBS (3:1) and were examined under
Olimpus confocal microscope Fluoview FV1000 (Melville, NY,
USA). The staining with EB dye was visualized by excitation
with 543-nm laser beams (green zone) and visualized as red
ﬂuorescence.
Inclined Plane Test
The inclined plane test consists in a platform of 1 meter long and
30 cm wide, with an analog protractor and hinged base, elevated
at 5◦ intervals until the animal slipped backwards (Chang et al.,
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FIGURE 1 | A sub-lethal dose of Shiga toxin 2 (Stx2) increases blood–brain barrier (BBB) permeability in the cerebellum. Evans blue (EB) staining was
employed to show permeability of the BBB (A–F). Saline-treated cerebellum (A–C). Fluorescence micrograph failing to detect EB staining (A). Light microscope
micrograph showing the same saline-treated area (B). Merge micrograph between micrographs (A) and (B) (C). Stx2-treated cerebellum (D–F). Fluorescence
micrograph showing EB staining in the parenchyma of Stx2-treated cerebellum (D). Light microscope micrograph showing the same Stx2-treated area (E). Merge
micrograph between micrographs (D) and (E) (F). Hematoxylin & Eosin staining of the observed area of the cerebellum showing the three layers involved in the
staining of EB: M, molecular; P, Purkinje and G, granular layers (G). Negative control of a cerebellum by not adding EB (H). Quantification of BBB permeability in the
cerebellum (I). Significant differences between toxin-treated and control group (∗p < 0.05). The scale bar in (G) applies to all micrographs.
2008; Lekic et al., 2011). The maximum angle at which a mouse is
able to maintain its position for at least 5 seconds constitutes the
inclined plane score (Wells et al., 2003). The inclined plane score
was determined in animals injected with vehicle or 0.5 and 1 ηg
of Stx2 at day 1, 3, 5 and 8 days following respective treatments.
Transmission Electron Microscopy
TEM analysis was performed to study ultrastructural changes
in the cerebellum following the treatments described in Section
“Animals”. Mice were anesthetized with Sodium pentobarbital
(60 mg/kg) and perfused transcardially with 0.9% NaCl solution
followed by 2.5% glutaraldehyde in 0.1 M phosphate buﬀer
[ﬁxative per animal/weight (ml/g)]. Brains were removed from
the skull and post-ﬁxed in the same ﬁxative solution for 2 h.
Samples of cerebella (3 mm2 thick) were dissected and collected
in 0.1 M phosphate buﬀer. The samples were ﬁrst assessed
by light microscopy with blue toluidine to select the areas
for TEM. Ultrathin sections were cut from selected areas and
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then contrasted with 1% osmium tetroxide and 1% uranyl
acetate, dehydrated and ﬂat-embedded in Durcupan (Priestley
et al., 1992). The sections were contrasted with lead citrate and
then examined and photographed on a Zeiss 109 TEM (Jena,
Germany). Adobe Photoshop software was used in the assembly
of images (Adobe Systems Inc., San Jose, CA, USA).
Neuronal damage caused by Stx2 was determined by EM and
consequently quantiﬁed. Neuronal damage was considered when
gathered at least one of these criteria: cell edema, vacuolated
cytoplasm, hypertrophic axons and/or retracted cytoplasm.
Quantiﬁcation of damaged Purkinje cells was determined and
expressed as a percentage of the total number of Purkinje neurons
in an area of 3721 μm2.
Statistical Analysis
The data are presented as mean ± SEM. In the case of BBB
permeability assay and damaged Purkinje cells analysis, statistical
signiﬁcance was performed using one-way analysis of variance
(ANOVA) followed by Student–Newman–Keuls post hoc tests. In
the case of comparison of diﬀerent treatment groups at diﬀerent
time points in the cerebellar functionality test, two ways analysis
of ANOVAwas used followed Bonferroni post hoc test (GraphPad
Prism 4, GraphPad Software, Inc.). The criterion for signiﬁcance
was p< 0.05 for all the experiments.
RESULTS
BBB Permeability of Cerebellum was
Increased by Stx2
It has been reported that Stx2 can pass through the BBB
aﬀecting the cell parenchyma (Goldstein et al., 2007). To
determine whether the toxin changes BBB permeability the EB
dye was perfused in each treated-mice group. Mice injected
i.v. with vehicle showed no permeability to the EB dye
(Figures 1A-C,G,H), indicating that the BBB was conserved. In
contrast, mice injected with 1 ηg of Stx2 showed an intense
ﬂuorescence staining in the parenchyma, indicating that EB
succeeded to pass through the BBB to the cerebellar parenchyma
(Figures 1D–F). Therefore, i.v. administration of Stx2 increased
the BBB permeability (Figure 1I).
Cerebellar Functionality was Altered by
Stx2
As Stx2 treatment provoked a deleterious eﬀect on the BBB by
increasing its permeability we asked whether the toxin may also
alter cerebellar functionality. For that purpose, a behavioral test
was made to evaluate the sensory-motor function in combination
with motor skills (hindlimb strength) on an inclined plane
which involved the cerebellar functionality. Lower scores denoted
poor cerebellar functionality by the Stx2-treated animals in
comparison to their controls. The most signiﬁcant lower score
was obtained in the higher dose group (1 ηg) after ﬁve days
of toxin administration (Figure 2). The control group (vehicle)
showed the best performance in the task (highest score), when
compared to the animals treated with 0.5 or 1 ηg of Stx2.
FIGURE 2 | Changes in cerebellar functionality by Stx2: quantification
of inclined plane scores at different days and for different treatments.
Significant differences between toxin-treated and control groups at the same
day (∗p < 0.05). Significant differences between 1 ηg toxin-treated and 0.5 ηg
toxin-treated groups at the same day (∗∗p < 0.05).
Stx2 Caused Profound Ultrastructural
Alterations in Purkinje Cells and
Granular Layers
Conserved Purkinje cells of the cerebellum from the vehicle-
treated group showed visible pale nuclei and well-dispersed
chromatin, intact cytoplasmic and nuclear membranes, and
intact cytoplasm (Bishop et al., 1980) (Figure 3A). In contrast,
neurons from the Stx2-treated group showed a progressive
neurodegenerative condition in a dose-dependent manner
(Figures 3B,C,G) compared to the vehicle-injected group
(Figure 3A,G). Five days after administration of 0.5 ηg of Stx2
the nuclei of Purkinje cells started to become shrunk, eccentric
and with edema (Figure 3B). In addition the bulk of chromatin
was more condensed. Cytoplasms became vacuolated and
electron-dense, and the axons were hypertrophic (Figure 3B).
In addition to this, granular cells from the granular layer
displayed similar ultrastructural alterations: nuclear edema,
discontinuous nuclear membrane, vacuolated and shrunken
cytoplasm (Figure 3E) a condition found in models of severe
encephalopathies (Yu et al., 1971). This was not observed in
granular cell layer from vehicle-treated-animals (Figure 3D).
When Stx2 was administered more concentrated (1 ηg) a
more profound ultrastructural alteration that resembled a
more neurodegenerative condition was observed. Purkinje cells
were found with abundant edema and retracted cytoplasm
(Figure 3C). Also, at this amount of toxin, cells from the granular
layer become shrunk, vacuolated and with necrotic appearance
(Figure 3F).
DISCUSSION
Motor behavioral alterations assessed by the inclined plane test
may be related to damage of cerebellar cells. In this report,
the deleterious eﬀect of sublethal intravenous Stx2 in the
cerebellum was demonstrated using behavioral, ultrastructural,
and physiological methodologies. Therefore, the current
results mimic cerebellar compromise usually reported in
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FIGURE 3 | A Sub-lethal dose of Stx2 causes cell damage in the cerebellum: dose response damage in Purkinje cells (A–C). dose response damage in
cells from the granular cell layer (D–F). Vehicle (A,D). Treatment with 0.5 ηg of Stx2 (B,E).Treatment with 1 ηg of Stx2 (C,F). Quantification of the percentage of
damaged neurons (G). Results are expressed as a percentage of the total number of neurons in an area of 3721 μm2. Significant differences between toxin-treated
and control groups (∗p < 0.05). Significant differences between 1 ηg toxin-treated and 0.5 ηg toxin-treated groups (∗∗p < 0.05). nu, nucleolus; n, nucleus; P,
Purkinje cell; e, edema; a, axon; pi, pycnotic cell; g, granular cell; asterisk, cell membrane; arrow, cell membrane. The scale bar in (A) applies to micrographs (B) and
(C). The scale bar in (E) applies to micrograph (F).
patients with neurological manifestations derived from HUS
(Hager et al., 1999; Steinborn et al., 2004; Donnerstag et al.,
2012).
The inclined plane task is a behavioral test that reveals
a cerebellar sensory-motor compromise. It tests the animal’s
ability to maintain its position and thus can be used as an
index of hindlimb strength (Fehlings and Tator, 1995), and
for determining cerebellar functionality in experimental animal
models of cerebellar lesions like cerebellar ataxia and cerebellar
hemorrhage (Fehlings and Tator, 1995; Wells et al., 2003; Chang
et al., 2008; Lekic et al., 2011). In addition, the integrity of
pyramidal and extrapyramidal systems may also be considered
in the performance of the task since peripheral Stx2 alters the
functionality of these structures as we previously described (Pinto
et al., 2013; Tironi-Farinati et al., 2013). The treatment of a
sub-lethal administration of Stx2 caused low performance in the
inclined plane task, in a dose response manner, during the early
period of assessment in comparison to controls.
MRI studies in children with diarrhea associated to HUS
showed nonspeciﬁc abnormalities in the cerebellum and these
studies failed to show any correlation between the onset of
neurological symptoms and MRI visible lesions (Donnerstag
et al., 2012). Furthermore, the extent of these lesions did
not correlate with the severity of neurological symptoms
(Weissenborn et al., 2012). In contrast to this, peripheral or
central administration of Stx2 succeeded to show by TEM
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deep alterations of the encephalon at the ultrastructural level
(Fujii et al., 1996, 1998, Goldstein et al., 2007). Moreover, in the
present work we certainly found a correlation between the altered
ultrastructure and the behavioral and physiological abnormalities
observed in toxin-treated animals. Therefore, the TEM technique
constitutes a reliable tool to observe evident ultrastructural
alterations in the cerebellum not detected by clinical routine
imaging techniques.
In a previous work, we found a neurodegenerative
ultrastructural phenotype in the brain striatum of mice (Tironi-
Farinati et al., 2013). In the present work we observed similar
ﬁndings in the cerebellum ofmice. Sub-lethal Stx2 administration
showed deep signs of neuronal damage. Purkinje and granular
cells showed a degenerative condition in a toxin-dose response
manner leading to cell death and this may occur through Gb3
receptor. It has been reported that Stx2 binds to Gb3 receptor in
neurons, including Purkinje and granular cells in the cerebellum
(Obata et al., 2008). Cerebellar cells in neurodegenerative
conditions associated with disease were frequently found in
animal models (Sato et al., 2012) or by drug injury (Sobaniec-
Lotowska, 2001). Overall, the altered changes observed in these
neurons reﬂect a pathological condition in Stx2-treated mice.
The precise cell mechanisms involved in the neuropathology are
still unknown and are under current investigation.
Other subtypes of Stx2 have been reported to produce
neurological compromise. It has been reported that Stx2c and
Stx2d caused damaged in the central nervous system (neuronal
and endothelial ultrastructural alterations) and neurological
symptoms (encephalopathy syndrome) in mice experimental
models (Fujii et al., 1994; Amran et al., 2013), similar to Stx2a
as it was observed in the present work and in a previous study
by our group (Tironi-Farinati et al., 2013). In addition Stx2e
induced the breakdown of the BBB and neurological disturbance
in a porcine model (Meisen et al., 2013), a similar ﬁnding to our
results.
In light of conclusive data presented, sub-lethal Stx2 altered
the BBB permeability in the cerebellum. This event allowed the
toxin to penetrate the cerebellar parenchyma that led to the
observed cell damage. Previous data presented by us and by other
colleagues demonstrated the capacity of the toxin to cross the
BBB in other brain areas (Mizuguchi et al., 1996; Fujii et al.,
1998; Goldstein et al., 2007). However, this is the ﬁrst report
acknowledging BBB permeability by the toxin in the cerebellum.
This experimental model allows us to explain the cerebellar
syndrome described in patients with HUS and may provide the
basis for future research in prevention of neurologic damage.
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